Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physiology of normal and abnormal blinking.

C N Karson1

  • 1Section on Clinical Brain Studies, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, D.C. 20032.

Advances in Neurology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phospholipid abnormalities in postmortem schizophrenic brains detected by 31P nuclear magnetic resonance spectroscopy: a preliminary study.

Psychiatry research·2001
Same author

Differential and region-specific activation of mitogen-activated protein kinases following chronic administration of phencyclidine in rat brain.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2001
Same author

Increased levels of transcription factors Elk-1, cyclic adenosine monophosphate response element-binding protein, and activating transcription factor 2 in the cerebellar vermis of schizophrenic patients.

Archives of general psychiatry·2000
Same author

Contribution of trifluoperazine metabolites to the in vivo (19)F NMR spectrum of rat brain.

Magnetic resonance in medicine·2000
Same author

Effects of antipsychotic drugs on metabolite ratios in rat brain in vivo.

Magnetic resonance in medicine·2000
Same author

Mitogen-activated protein kinases in schizophrenia.

Biological psychiatry·1999
Same journal

Future and alternative therapies in Tourette syndrome.

Advances in neurology·2006
Same journal

Behavioral neurosurgery.

Advances in neurology·2006
Same journal

Behavior therapy: other interventions for tic disorders.

Advances in neurology·2006
Same journal

Behavioral treatments for tic suppression: habit reversal training.

Advances in neurology·2006
Same journal

Treatment of aggression in Tourette syndrome.

Advances in neurology·2006
Same journal

Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.

Advances in neurology·2006
See all related articles

Blink rate, influenced by various factors, is closely linked to central nervous system dopamine activity. Reduced blinking in Parkinson's disease suggests nigrostriatal system involvement, offering a potential clinical probe.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Dopamine Neurotransmission

Background:

  • Blink rate is influenced by ocular, visual, cognitive, and arousal factors, mediated by neuroanatomic structures.
  • Dopamine, particularly via the D2 receptor, is the primary neurotransmitter linked to blink rate regulation.
  • Dysfunctions in blinking are observed in neurological conditions like Parkinson's disease and progressive supranuclear palsy (PSP).

Purpose of the Study:

  • To explore the neuroanatomic underpinnings of blink rate control.
  • To investigate the role of dopamine systems in blink rate regulation and associated neurological disorders.
  • To assess the potential of blink rate as a noninvasive marker for central nervous system (CNS) dopamine activity.

Main Methods:

  • Review of existing literature on factors influencing blink rate.

Related Experiment Videos

  • Analysis of neuroanatomic structures implicated in blinking.
  • Correlation of blink rate changes with dopamine system activity in neurological conditions.

    • Main Results:

    • Reduced blink rates in Parkinson's disease suggest involvement of the nigrostriatal system.
    • Reduced blinking in PSP and sylvian aqueduct syndrome point towards periaqueductal and superior colliculus involvement.
    • Lack of association between most dyskinesias and increased blinking suggests their pathophysiology may not involve CNS dopamine hyperactivity.

    Conclusions:

    • Blink rate serves as a noninvasive probe for CNS dopamine activity.
    • Blink rate monitoring is clinically valuable in parkinsonism for tracking disease severity and dopamine agonist side effects.
    • Further research is needed to fully elucidate the complex neurochemical anatomy of blinking.